Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd

Bullboard Posts

Comment by Fundy13on Nov 21, 2018 2:16pm

232 Views

Post# 29006004

RE:RE:RE:RE:RE:RE:From Analyist

Well today was the 30 days and no announcement so something is making this take longer then originally stated.
If I had to guess and this is pure speculation I would say maybe HUGE is trying to get the definitive agreement at a set SP.
If they sign a difinitive agreement using 20 day moving average and the SP drops back to $0.13 they would be giving away a pretty big chunk of the company.
I would have to think HUGE is smart enough to know the SP could drop after this announcement as it is pretty common for that to happen, plus the stock was already on a downward trend from the $0.94 high.

Bullboard Posts

Changing Europe’s dependency on HREE from China